Rachelle R. Sowell

Next Post

Cannformatics Unlocks Medical Cannabis' Mechanism of Action in Children with Autism Spectrum Disorder

Tue Apr 5 , 2022
Corporation Identifies 22 New Possible Lipid-Dependent Cannabis-Responsive™ biomarkers. SAN FRANCISCO, March 29, 2022 /PRNewswire/ — Cannformatics, an early-stage biotechnology startup, declared that it identified 22 new prospective lipid-centered Cannabis-Responsive™ biomarkers in the saliva of children with autism spectrum condition (ASD). All 22 biomarkers shifted towards the physiological selection of usually […]